Biomarkers for Fibrotic Diseases
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 10 July 2026 | Viewed by 15
Special Issue Editors
Interests: lung fibrosis; macrophages; metabolism; mechanosignaling
Special Issues, Collections and Topics in MDPI journals
Interests: lung fibrosis; environmental exposure; mitochondria; metabolism; immunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Fibrotic diseases such as pulmonary fibrosis, systemic sclerosis, liver cirrhosis, and chronic kidney disease cause progressive organ failure and remain a major unmet medical challenge. Reliable biomarkers for early detection, disease monitoring, and therapeutic response are urgently needed. This Special Issue highlights advances in the identification and validation of biomarkers that reflect key fibrotic processes, including immune activation, mechanotransduction, and extracellular matrix remodeling. We welcome studies employing multi-omics, spatial, and imaging-based approaches to uncover molecular and cellular signatures of fibrosis across organ systems. Translational and clinical studies linking biomarker dynamics to disease outcomes or treatment response are particularly encouraged. By integrating insights across disciplines, this collection aims to accelerate the development of precision diagnostics and targeted therapies for fibrotic diseases.
Dr. Chao He
Dr. Jennifer Casey
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fibrosis
- biomarkers
- multi-omics
- machine learning
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
